Liang-Liang Shi (Liangliang Shi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Chemotherapy Induced

Top Venues

Cancer immunology, immunotherapy : CII

Canadian respiratory journal

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

This page only lists publications with an associated author ORCID identifier.

Publications

Xixi Liu, Bian Wu, Jing Huang, You Qin, Zhanjie Zhang, Liang-Liang Shi, Xiaohua Hong, Qian Ding, Gang Peng, Kunyu Yang
Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy. Head & neck 44 (4) (2022)
Jun Li, Gang Peng, Kuikui Zhu, Xiaohua Jie, Yingzhuo Xu, Xinrui Rao, Yunhong Xu, Yunshang Chen, Biyuan Xing, Gang Wu, Liang-Liang Shi
PD-1 + mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy. Cancer immunology, immunotherapy : CII (2022)
Bin Yang, Yan Wang, Zhuoying Chen, Yi-Ming Feng, Liang-Liang Shi
Effects of Apatinib on the "Stemness" of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms. Canadian respiratory journal 2020 (2020)
Qiu-Ting Li, Yi-Ming Feng, Zun-Hui Ke, Meng-Jun Qiu, Xiao-Xiao He, Meng-Meng Wang, Ya-Nan Li, Jing Xu, Liang-Liang Shi, Zhi-Fan Xiong
KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 68 (1) (2019)